Contrarily, shRNA-mediated silencing or CRISPR/Cas9-induced knockout (KO) of POLRMT potently suppressed osteosarcoma cell growth in vitro and in vivo [19]. The gene discussed is POLRMT; the disease is osteosarcoma.